Skip to content
Clinical Trials – home
Universitaetsklinikum Tuebingen AöR
Sponsor

Universitaetsklinikum Tuebingen AöR

Germany Geissweg 3, Innenstadt, 72076 Tuebingen, Germany

About the sponsor

Clinical research includes acute myeloid leukemia, myelodysplastic neoplasms, chronic lymphocytic leukemia, lymphoma, and acute lymphoblastic leukemia, with activity across relapsed, refractory, and post-transplant settings.

  • Allogeneic stem cell transplantation
  • B-cell malignancies
  • Minimal residual disease
  • Leukemia vaccination

Research also covers fusion-driven sarcomas, fibrolamellar hepatocellular carcinoma, and immunotherapy-based approaches in advanced blood cancers and solid tumors.

About Specializations

Universitaetsklinikum Tuebingen AöR runs clinical trials in conditions such as Acute myeloid leukaemia, Parkinson's disease, Acute lymphocytic leukaemia, Retinopathy of prematurity, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

22 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Treosulfan
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Levodopa
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:MB-CART2219.1
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Tafasitamab
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Zirconium (89Zr) Crefmirlimab Berdoxam
  • Sponsor:Universitaetsklinikum Tuebingen AöR

Depression

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Decitabine
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Pervi-Fus
  • Sponsor:Universitaetsklinikum Tuebingen AöR
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Propranolol Hydrochloride
  • Sponsor:Universitaetsklinikum Tuebingen AöR

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.